Ayuvya and Imfresh walked into Shark Tank India Season 5 with the boldest valuation of any consumer brand in this series — ₹200 crore, sought by offering just half a percent of the company. The Sharks did not bite.
- What are Ayuvya and Imfresh?
- The pitch: Rs 1 crore for 0.5% equity
- Why a 0.5% ask is a difficult opening position
- It leaves no room to negotiate
- The stake is too small to be worth the involvement
- Two brands in one pitch splits the story
- Beauty was a hard sell all season
- What founders should take away
- Frequently Asked Questions
- Did Ayuvya get a deal on Shark Tank India Season 5?
- What valuation did Ayuvya ask for?
- What do Ayuvya and Imfresh sell?
- Why did the Sharks reject the pitch?
- The bottom line
What are Ayuvya and Imfresh?
The pitch covered two connected propositions: Ayurveda-based supplements and beauty products. It sits in a category that has grown substantially as Indian consumers have moved toward traditional formulations for wellness, hair care and skin concerns.
The tailwinds are genuine. Ayurveda carries built-in cultural credibility in India that no imported wellness claim can match. Government support for AYUSH systems has raised the category’s legitimacy, and consumer preference has shifted toward products perceived as natural. Several Ayurveda-led brands have built substantial businesses on exactly this foundation.
The pitch: Rs 1 crore for 0.5% equity
The founders asked for ₹1 crore for 0.5% equity, implying a ₹200 crore valuation.
To put that in the context of Season 5’s other consumer pitches:
| Brand | Category | Valuation asked | Outcome |
|---|---|---|---|
| Ayuvya & Imfresh | Ayurveda supplements, beauty | ₹200 crore | No deal |
| True Diamond | Lab-grown diamonds | ₹108 crore | No deal |
| Lewisia Wellness | Natural skincare | ₹100 crore | No deal |
| Croffle | Dessert brand | ₹100 crore | Deal at ₹50 crore |
This was the highest consumer valuation of the season covered in this series, and the smallest equity offering.
Why a 0.5% ask is a difficult opening position
It leaves no room to negotiate
A founder offering 0.5% is signalling that the valuation is not up for discussion. Investors who disagree with the number have nowhere to go except to reject it outright. Compare Neurapexai, which offered 5% at ₹12 crore and closed at exactly the ask, or Stroom, which offered 2% at ₹50 crore and took a mild 20% cut.
The stake is too small to be worth the involvement
Half a percent of a company does not justify an investor’s time, network and reputational backing. Sharks on this show consistently push toward stakes that make active participation worthwhile. Advisory equity structures appeared repeatedly in Season 5 for precisely this reason.
Two brands in one pitch splits the story
Pitching Ayuvya and Imfresh together requires the investors to underwrite two propositions at once. Supplements and beauty products have different regulatory requirements, different purchase drivers and different distribution channels. Focus is one of the things investors are actively looking for, and a combined pitch works against it.
Beauty was a hard sell all season
Lewisia Wellness had already been rejected in Episode 1 at half this valuation. With Shaily Mehrotra of FixDerma and Varun Alagh of Mamaearth on the expanded Season 5 panel, beauty pitches faced questioning from people who had personally built at scale in the category.
What founders should take away
- A low equity offer reads as a high valuation, not as modesty. Every sub-1% ask in this series either got heavily cut or rejected outright — with Kalam Labs the sole exception, and that was deep tech with a genuine moat.
- Pitch one business. If you run two brands, lead with the stronger one and mention the other as an extension.
- Category credibility is not a valuation argument. Ayurveda’s cultural strength explains why customers buy. It does not explain why this particular company is worth ₹200 crore.
Frequently Asked Questions
Did Ayuvya get a deal on Shark Tank India Season 5?
No. The Ayuvya and Imfresh pitch asked for ₹1 crore for 0.5% equity and did not receive an offer.
What valuation did Ayuvya ask for?
₹1 crore for 0.5% equity implies a ₹200 crore valuation — the highest consumer ask in this series.
What do Ayuvya and Imfresh sell?
Ayurveda-based supplements and beauty products.
Why did the Sharks reject the pitch?
The combination of a ₹200 crore valuation, a 0.5% equity offer that left little room to negotiate, and two separate brands presented together made the proposition difficult to underwrite.
The bottom line
Ayuvya and Imfresh asked the highest price of any consumer brand in this series while offering the smallest slice of the company. Season 5 was unusually consistent on this point: the panel rewarded founders who priced defensibly and offered a stake worth having. This pitch did neither, and a strong category could not make up the difference.
